December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Regeneron Pharmaceuticals (NQ: REGN )

542.73 USD +4.95 (+0.92%)
Streaming Delayed Price Updated: 12:56 PM EST, Jan 25, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Regeneron Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Pharma Stock Ideas: Why BMO Is Recommending Regeneron, Constellation
Afterstrong performance in 2020, biopharma stocks are expected to continue their winning run in the new year. Among the ... 
Tags Small Cap Matthew Luchini Price Target
From Benzinga
Why Aurinia Pharma, AstraZeneca And More Are Trading Higher Today
AstraZeneca (NASDAQ: AZN) shares are trading higher Monday after the company's CALQUENCE met its primary efficacy endpoint. The ... 
Tags AUPH Movers why it's moving
From Benzinga
Dow Jones Today, Futures Mixed As Merck Exits Covid Vaccine Race; Apple, Microsoft, AMD Rise Ahead Of Earnings
SciPlay and Regeneron were early leaders, Apple led the Dow Jones today as stock futures geared for the heaviest week of the Q4 reporting season. 
From Investor's Business Daily
Analysts Expect FBT To Hit $207
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Biden Stocks: 16 Stocks to Watch for a Defense Production Act Boost
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Biden stocks like APT stock, KODK stock, MMM stock and CAH stock are all... 
Tags BDX GILD MSA
From InvestorPlace
Noteworthy Wednesday Option Activity: REGN, SBH, WRLD
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Regeneron Pharmaceuticals, Inc. (REGN), where a total of 6,227 contracts have traded so far,... 
Tags Stocks
From Market News Video
My Biotech Investing Advice for 2021
The J.P. Morgan Healthcare Conference is the most important healthcare investment conference of the year. 
Tags Healthcare Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
The Biggest Drug Competition in 2021 (Hint: It Isn't COVID Vaccines)
Investors should take notice of this four-way competition. 
Tags PFE Market News ABBV
From Motley Fool
IBB, AMGN, GILD, REGN: Large Inflows Detected at ETF
Symbols mentioned in this story: IBB, AMGN, GILD, REGN Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
Learning From Stock Market Losers
Rule Breaker Investing: David's Biggest Losers Volume 6 
Tags AAPL CRWD FVRR
From Motley Fool
Will the New Coronavirus Strain Affect Vaccines' Efficacy?
There's good news. 
Tags Market News MRNA REGN
From Motley Fool
Could Regeneron Pharmaceuticals Be a Millionaire-Maker Stock?
This high-growing, blue-chip biotech has just what it takes to make investors rich. 
Tags Market News REGN
From Motley Fool
Noteworthy Wednesday Option Activity: EOG, REGN, GPS
Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in EOG Resources, Inc. (EOG), where a total of 26,030 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
Why Regeneron, Jaguar Health And Seneca Are Moving Today
Regeneron Pharmaceuticals (NASDAQ: REGN) shares are trading higher after the company announced an additional U.S. order to purchase 1.25 ... 
Tags Trading Ideas SNCA REGN
From Benzinga
Is Regeneron Stock Heading to $590?
Rapid expansion beyond the Eylea franchise is causing analysts to raise their ratings on the big biotech. 
Tags REGN SNY Market News
From Motley Fool
U.S. sees record one-day death toll and experts worry that new variant may make activities like plane travel more risky
The U.S. set another grim milestone in the coronavirus pandemic on Tuesday, when more than 4,400 COVID-19 patients died, the most in a single day since the start of the outbreak, and experts said that... 
Tags JNJ REGN General
From MarketWatch
Benzinga's Top Upgrades, Downgrades For January 13, 2021
Upgrades Nomura Instinet upgraded the previous rating for General Motors Co (NYSE:GM) from Neutral to Buy. In the third ... 
Tags NHI GM Benzinga
From Benzinga
5 Penny Stocks to Watch If Biotech Stocks Are Your Focus in January 2021
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Dow Jones Today, Futures Drift Ahead Of Second Trump Impeachment Vote; Regeneron, General Motors Jump
GM was an early leader, Home Depot topped the Dow Jones today, but stock futures shifted lower as Congress moved toward a vote to impeach President Trump. 
From Investor's Business Daily
Dow futures drift lower ahead of inflation data, impeachment vote
Stock-index futures drift slightly lower as investors await data on inflation and a House vote on impeaching President Donald Trump a week before he is set to leave office. 
Tags REGN YM00 COMP
From MarketWatch
Regeneron To Supply US With Another 1.25M COVID-19 Treatment Doses
Biotech company Regeneron Pharmaceuticals Inc (NASDAQ: REGN) announced the signing of a $2.625 billion supply agreement with the U.S. ... 
Tags News Benzinga REGN
From Benzinga
Are These The Best Biotech Stocks To Buy This Month?
Tags Market News
From Stockmarket.com
Sanofi Spins Off an Industry-Leading Business
After divesting its active pharmaceutical ingredient segment, the slimmed-down company will have more time to focus on developing new blockbuster drugs. 
Tags Market News REGN SNY
From Motley Fool
Market Briefing For Friday, Jan. 7
Whether the President stays for 12 more days or not hangs in the balance for now; although it doesn't seem to be a market factor. 
From Blogs - TalkMarkets
Market Briefing For Thursday, Jan. 6
Insurrection at the Heart of our Republic, the U.S. Capitol, instigated very clearly by none other than the outgoing President, plus complicit behavior by a few politicians, cannot be whitewashed by... 
Tags Energy Commodities Pharma/Biotech
From Blogs - TalkMarkets
My biggest blunders last year could help keep us from making the same mistakes in 2021 and beyond
Michael Brush gives his perspective on a confounding year. Some lessons: Be humble, be wary of the crowd. 
Tags GILD MAR LVS
From MarketWatch
Where to Invest $100,000 Right Now
The key is diversification -- and a focus on companies showing strength today and promise of long-term growth. 
Tags AMZN TSLA Market News
From Motley Fool
This Small Gene Therapy Stock Is Taking On Giants Regeneron, Roche
Regenxbio launched a key study of its eye disease-targeting gene therapy, prompting RGNX stock to pop on Wednesday. It's also planning to test a gene therapy in muscular dystrophy. 
From Investor's Business Daily
This Small Gene Therapy Stock Is Taking On Giants Regeneron, Roche
Regenxbio launched a key study of its eye disease-targeting gene therapy, prompting RGNX stock to pop on Wednesday. It's also planning to test a gene therapy in muscular dystrophy. 
From Investor's Business Daily
Noteworthy Tuesday Option Activity: TDOC, SBUX, REGN
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Teladoc Health Inc (TDOC), where a total of 12,594 contracts have traded so far,... 
Tags Stocks
From Market News Video
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.